#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16756	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2206	751.7	0	.	n	.	0	C451T	SNP	451	451	C	787	787	T	930	T,C	891,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16756	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2206	751.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1520	1520	C	943	C,T	877,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3415	870.6	0	.	n	.	0	T695C	SNP	695	695	T	946	946	C	897	C,T	838,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3415	870.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2222	2222	C	948	C,T	892,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3415	870.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2296	2296	A	937	A	892	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3415	870.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2848	2848	C	912	C,T,A	649,205,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30032	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3415	870.6	0	HET	.	.	.	C2187T	.	2187	2187	C	2438	2438	C	848	C,T	620,164	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2266	folP	855	855	100.0	folP.l15.c4.ctg.1	1587	141.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1061	1063	AGC	251;249;250	A;G;C	234;234;232	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6668	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	197.4	1	SNP	p	S91F	1	.	.	271	273	TTC	464	466	TTC	226;229;232	T;T;C	217;220;221	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6668	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	197.4	1	SNP	p	D95G	1	.	.	283	285	GGC	476	478	GGC	232;234;235	G,T;G;C	217,2;222;218	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6668	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	197.4	1	SNP	p	G95N	0	.	.	283	285	GGC	476	478	GGC	232;234;235	G,T;G;C	217,2;222;218	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1906	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1311	144.5	1	SNP	p	G45D	0	.	.	133	135	GGC	440	442	GGC	229;226;226	G;G;C	216;208;209	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1012	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	990	101.0	0	.	n	.	0	A197.	DEL	197	197	A	568	568	A	239	A	223	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6218	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2943	209.1	1	SNP	p	D86N	0	.	.	256	258	GAC	551	553	GAC	251;250;251	G;A;C	232;227;231	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6218	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2943	209.1	1	SNP	p	R87W	0	.	.	259	261	CGT	554	556	CGT	251;250;251	C;G;T	233;228;224	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6218	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2943	209.1	1	SNP	p	R87I	0	.	.	259	261	CGT	554	556	CGT	251;250;251	C;G;T	233;228;224	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6218	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2943	209.1	1	SNP	p	S87R	1	.	.	259	261	CGT	554	556	CGT	251;250;251	C;G;T	233;228;224	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6218	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2943	209.1	1	SNP	p	S88P	0	.	.	262	264	TCC	557	559	TCC	255;254;256	T;C;C,A	232;235;239,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5118	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2744	184.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1590	1592	GGC	238;237;236	G;G;C	230;228;224	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1213	1215	GCC	228;228;228	G;C;C	214;215;217	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1216	1218	ATG	230;232;230	A;T;G	219;220;216	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1228	1230	ACC	229;231;234	A;C;C	216;220;221	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1228	1230	ACC	229;231;234	A;C;C	216;220;221	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1729	1731	ACC	207;207;210	A;C;C	182;187;194	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1783	1785	GCG	224;222;221	G;C;G	209;205;204	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1783	1785	GCG	224;222;221	G;C;G	209;205;204	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1906	1908	GGT	202;201;202	G;G;T	187;187;186	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1915	1917	AGC	190;188;191	A;G;C	175;175;177	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4516	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2443	183.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1933	1935	CCG	179;184;184	C,G;C,G,T;G	136,10;139,2,1;144	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6600	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3090	211.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1651	1653	CCG	248;246;245	C;C;G	210;221;213	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3094	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1784	171.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	532	532	C	257	C	236	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3080	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1678	182.0	0	.	p	.	0	I45V	NONSYN	133	135	ATT	493	495	GTT	262;262;259	G;T;T	248;249;245	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3080	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1678	182.0	0	.	p	.	0	G50D	NONSYN	148	150	GGC	508	510	GAC	236;237;236	G;A;C,T	222;224;224,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3080	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1678	182.0	1	SNP	p	G120K	1	.	.	358	360	AAG	718	720	AAG	227;230;231	A;A;G	214;215;210	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3080	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1678	182.0	1	SNP	p	A121N	1	.	.	361	363	AAC	721	723	AAC	230;227;227	A;A;C	214;209;212	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3080	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1678	182.0	1	SNP	p	N121D	0	.	.	361	363	AAC	721	723	AAC	230;227;227	A;A;C	214;209;212	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11494	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4904	232.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1184	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1151	102.4	1	SNP	p	V57M	1	.	.	169	171	ATG	613	615	ATG	264;266;263	A;T;G,A	252;255;254,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
